ArticleJournal for immunotherapy of cancer2025

Tandem CAR-T cells targeting mesothelin and MUC16 overcome tumor heterogeneity by targeting one antigen at a time.

Diego Salas-Benito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.